MiMedx Group, Inc. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
MiMedx Group, Inc. (MDXG) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2023-02-28
- MiMedx Group, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2019-12-31 was -$354.00K.
- MiMedx Group, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2019-09-30 was $0.00.
- MiMedx Group, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2019-06-30 was $0.00.
- MiMedx Group, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2019-03-31 was $800.00K.
- MiMedx Group, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2022 was $0.00.
- MiMedx Group, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2021 was $0.00.
- MiMedx Group, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- MiMedx Group, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2019 was $446.00K.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 | $53.00K 10-K · filed 2022-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | $1.03M 10-K · filed 2021-03-08 | |||
| 2019-12-31 | -$354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$354.00K derived: sum of 2 quarters · filed 2022-02-28 | -$354.00K derived: sum of 3 quarters · filed 2022-02-28 | $446.00K 10-K · filed 2022-02-28 | $1.30M 10-K · filed 2020-07-06 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-04 | $0.00 derived: sum of 2 quarters · filed 2020-11-04 | $800.00K 10-Q · filed 2020-11-04 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-04 | $800.00K 10-Q · filed 2020-08-04 | |||
| 2019-03-31 | $800.00K 10-Q · filed 2020-07-06 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-08 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2020-07-06 | ||||
| 2017-12-31 | $600.00K 10-K · filed 2020-07-06 | $590.00K 10-K · filed 2020-03-17 | |||
| 2016-12-31 | $0.00 10-K · filed 2020-03-17 | ||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |